Consonance Capital Management LP 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:58 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 0 0.000% | -470,344 (Position Closed) | Filing |
| 2021-02-17 3:10 pm Sale | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 470,344 9.990% | -135,507 (-22.37%) | Filing |
| 2021-02-16 2:20 pm Purchase | 2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 605,851 9.990% | 605,851 (New Position) | Filing |